CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.

In humans, NK receptors are expressed by natural killer cells and some T cells, the latter of which are preferentially alphabetaTCR+ CD8+ cytolytic T lymphocytes (CTL). In this study we analyzed the expression of nine NK receptors (p58.1, p58.2, p70, p140, ILT2, NKRP1A, ZIN176, CD94 and CD94/NKG2A)...

Full description

Bibliographic Details
Main Authors: Speiser, D, Valmori, D, Rimoldi, D, Pittet, M, Liénard, D, Cerundolo, V, MacDonald, H, Cerottini, J, Romero, P
Format: Journal article
Language:English
Published: 1999
_version_ 1797089020972367872
author Speiser, D
Valmori, D
Rimoldi, D
Pittet, M
Liénard, D
Cerundolo, V
MacDonald, H
Cerottini, J
Romero, P
author_facet Speiser, D
Valmori, D
Rimoldi, D
Pittet, M
Liénard, D
Cerundolo, V
MacDonald, H
Cerottini, J
Romero, P
author_sort Speiser, D
collection OXFORD
description In humans, NK receptors are expressed by natural killer cells and some T cells, the latter of which are preferentially alphabetaTCR+ CD8+ cytolytic T lymphocytes (CTL). In this study we analyzed the expression of nine NK receptors (p58.1, p58.2, p70, p140, ILT2, NKRP1A, ZIN176, CD94 and CD94/NKG2A) in PBL from both healthy donors and melanoma patients. The percentages of NK receptor-positive T cells (NKT cells) varied strongly, and this variation was more important between individual patients than between individual healthy donors. In all the individuals, the NKT cells were preferentially CD28-, and a significant correlation was found between the percentage of CD28- T cells and the percentage of NK receptor+ T cells. Based on these data and the known activated phenotype of CD28- T cells, we propose that the CD28- CD8+ T cell pool represents or contains the currently active CTL population, and that the frequent expression of NK receptors reflects regulatory mechanisms modulating the extent of CTL effector function. Preliminary results indicate that some tumor antigen-specific T cells may indeed be CD28- and express NK receptors in vivo.
first_indexed 2024-03-07T02:58:29Z
format Journal article
id oxford-uuid:b021a97c-e7cf-4cee-a52d-a71f1de0536a
institution University of Oxford
language English
last_indexed 2024-03-07T02:58:29Z
publishDate 1999
record_format dspace
spelling oxford-uuid:b021a97c-e7cf-4cee-a52d-a71f1de0536a2022-03-27T03:54:13ZCD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b021a97c-e7cf-4cee-a52d-a71f1de0536aEnglishSymplectic Elements at Oxford1999Speiser, DValmori, DRimoldi, DPittet, MLiénard, DCerundolo, VMacDonald, HCerottini, JRomero, PIn humans, NK receptors are expressed by natural killer cells and some T cells, the latter of which are preferentially alphabetaTCR+ CD8+ cytolytic T lymphocytes (CTL). In this study we analyzed the expression of nine NK receptors (p58.1, p58.2, p70, p140, ILT2, NKRP1A, ZIN176, CD94 and CD94/NKG2A) in PBL from both healthy donors and melanoma patients. The percentages of NK receptor-positive T cells (NKT cells) varied strongly, and this variation was more important between individual patients than between individual healthy donors. In all the individuals, the NKT cells were preferentially CD28-, and a significant correlation was found between the percentage of CD28- T cells and the percentage of NK receptor+ T cells. Based on these data and the known activated phenotype of CD28- T cells, we propose that the CD28- CD8+ T cell pool represents or contains the currently active CTL population, and that the frequent expression of NK receptors reflects regulatory mechanisms modulating the extent of CTL effector function. Preliminary results indicate that some tumor antigen-specific T cells may indeed be CD28- and express NK receptors in vivo.
spellingShingle Speiser, D
Valmori, D
Rimoldi, D
Pittet, M
Liénard, D
Cerundolo, V
MacDonald, H
Cerottini, J
Romero, P
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title_full CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title_fullStr CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title_full_unstemmed CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title_short CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
title_sort cd28 negative cytolytic effector t cells frequently express nk receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients
work_keys_str_mv AT speiserd cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT valmorid cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT rimoldid cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT pittetm cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT lienardd cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT cerundolov cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT macdonaldh cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT cerottinij cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients
AT romerop cd28negativecytolyticeffectortcellsfrequentlyexpressnkreceptorsandarepresentatvariableproportionsincirculatinglymphocytesfromhealthydonorsandmelanomapatients